Literature DB >> 17717444

Specific polymorphic variation in the mitochondrial genome and increased in-hospital mortality after severe trauma.

Jeffrey A Canter1, Patrick R Norris, Jason H Moore, Judith M Jenkins, John A Morris.   

Abstract

OBJECTIVE: To determine whether specific genetic variations in the mtDNA that impact energy production and free-radical generation are potential new risk factors for in-hospital mortality after severe trauma. SUMMARY BACKGROUND DATA: Each of the 3 mitochondrial DNA polymorphisms selected for this study (at positions 4216, 10398, 4917) alter the amino acid sequence of different key subunits of Complex I in the electron transport chain. They have been previously implicated in phenotypes involving tissues with high-energy demand, such as the brain and retina.
METHODS: Seven hundred forty-five consecutive patients admitted to the trauma intensive care unit at Vanderbilt University Medical Center between April 11, 2005, and February 27, 2006, were potentially eligible for this study. Under an Institutional Review Board-approved protocol (which excluded patients <18 years of age and prisoners), 666 patients had DNA extracted from a blood sample. Detailed demographic and clinical covariates were also obtained (including age, gender, ethnicity, lactate measurements, and injury severity score). A flurogenic 5' nuclease allelic discrimination Taqman assay and the ABI 7900HT Sequence Detection System (v2.1) was used to genotype the T4216C, A10398G, and A4917G polymorphisms. The primary outcome was in-hospital mortality.
RESULTS: Multivariate logistic regression analysis revealed that the 4216T allele was a significant independent predictor of in-hospital mortality (OR = 2.63, 95% CI 1.14-6.07, P = 0.02) after adjustment for age, gender, injury severity score, highest lactate level, mechanism of injury, and the 10398 polymorphism.
CONCLUSIONS: Variation in the mtDNA, specifically the 4216T allele, appears to increase the risk of in-hospital mortality after severe injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17717444      PMCID: PMC1959353          DOI: 10.1097/SLA.0b013e3181469955

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  41 in total

1.  Mitochondrial oxidative phosphorylation defects in Parkinson's disease.

Authors:  D C Wallace; J M Shoffner; R L Watts; J L Juncos; A Torroni
Journal:  Ann Neurol       Date:  1992-07       Impact factor: 10.422

2.  Normal oxidative damage to mitochondrial and nuclear DNA is extensive.

Authors:  C Richter; J W Park; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

3.  Sequence and organization of the human mitochondrial genome.

Authors:  S Anderson; A T Bankier; B G Barrell; M H de Bruijn; A R Coulson; J Drouin; I C Eperon; D P Nierlich; B A Roe; F Sanger; P H Schreier; A J Smith; R Staden; I G Young
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

4.  Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis?

Authors:  Michelangelo Mancuso; Francesca Luisa Conforti; Anna Rocchi; Alessandro Tessitore; Maria Muglia; Gioacchino Tedeschi; Daniela Panza; MariaRosaria Monsurrò; Patrizia Sola; Jessica Mandrioli; Anna Choub; Alberto DelCorona; Maria Laura Manca; Rosalucia Mazzei; Teresa Sprovieri; Massimiliano Filosto; Alessandro Salviati; Paola Valentino; Francesco Bono; Manuela Caracciolo; Isabella Laura Simone; Vincenzo La Bella; Giovanni Majorana; Gabriele Siciliano; Luigi Murri; Aldo Quattrone
Journal:  Neurosci Lett       Date:  2004-11-23       Impact factor: 3.046

5.  The staged celiotomy for trauma. Issues in unpacking and reconstruction.

Authors:  J A Morris; V A Eddy; T A Blinman; E J Rutherford; K W Sharp
Journal:  Ann Surg       Date:  1993-05       Impact factor: 12.969

6.  Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients.

Authors:  J M Shoffner; M D Brown; A Torroni; M T Lott; M F Cabell; S S Mirra; M F Beal; C C Yang; M Gearing; R Salvo
Journal:  Genomics       Date:  1993-07       Impact factor: 5.736

7.  Mitochondrial DNA polymorphisms as risk factors for Parkinson's disease and Parkinson's disease dementia.

Authors:  Jaana Autere; Jukka S Moilanen; Saara Finnilä; Hilkka Soininen; Arto Mannermaa; Päivi Hartikainen; Merja Hallikainen; Kari Majamaa
Journal:  Hum Genet       Date:  2004-04-24       Impact factor: 4.132

Review 8.  Mitochondrial DNA sequence variation in human evolution and disease.

Authors:  D C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

9.  Analysis of European mitochondrial haplogroups with Alzheimer disease risk.

Authors:  Joelle M van der Walt; Yulia A Dementieva; Eden R Martin; William K Scott; Kristin K Nicodemus; Charles C Kroner; Kathleen A Welsh-Bohmer; Ann M Saunders; Allen D Roses; Gary W Small; Donald E Schmechel; P Murali Doraiswamy; John R Gilbert; Jonathan L Haines; Jeffery M Vance; Margaret A Pericak-Vance
Journal:  Neurosci Lett       Date:  2004-07-15       Impact factor: 3.046

Review 10.  Mitochondrial oxidative stress and mitochondrial DNA.

Authors:  Dongchon Kang; Naotaka Hamasaki
Journal:  Clin Chem Lab Med       Date:  2003-10       Impact factor: 3.694

View more
  4 in total

1.  Life or death? A physiogenomic approach to understand individual variation in responses to hemorrhagic shock.

Authors:  Harold G Klemcke; Bina Joe; Rajiv Rose; Kathy L Ryan
Journal:  Curr Genomics       Date:  2011-09       Impact factor: 2.236

2.  Survival and mitochondrial function in septic patients according to mitochondrial DNA haplogroup.

Authors:  Leonardo Lorente; Ruth Iceta; María M Martín; Esther López-Gallardo; Jordi Solé-Violán; José Blanquer; Lorenzo Labarta; César Díaz; Alejandro Jiménez; Julio Montoya; Eduardo Ruiz-Pesini
Journal:  Crit Care       Date:  2012-01-17       Impact factor: 9.097

Review 3.  Bench-to-bedside review: latest results in hemorrhagic shock.

Authors:  Martin K Angele; Christian P Schneider; Irshad H Chaudry
Journal:  Crit Care       Date:  2008-07-10       Impact factor: 9.097

4.  Severe septic patients with mitochondrial DNA haplogroup JT show higher survival rates: a prospective, multicenter, observational study.

Authors:  Leonardo Lorente; Ruth Iceta; María M Martín; Esther López-Gallardo; Jordi Solé-Violán; José Blanquer; Lorenzo Labarta; César Díaz; Juan María Borreguero-León; Alejandro Jiménez; Julio Montoya; Eduardo Ruiz-Pesini
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.